Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic Neuropathy
NCT ID: NCT00993070
Last Updated: 2012-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
33 participants
INTERVENTIONAL
2009-10-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
0.075% Capsaicin Lotion for the Treatment of Painful Diabetic Neuropathy
NCT03113448
Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy
NCT01125215
Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot Pain
NCT07260656
Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain
NCT02228928
The Role of TRP Channels in DPN
NCT07237022
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Outcome will be assessed by visual analog scale, neuropathic pain scale, SF-MPQ, SF-36. Safety and tolerability will be recorded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Capsaicin
Capsaicin
0.025% topical capsaicin applied 4 times per day for 8 weeks
placebo
placebo
vehicle gel, applied 4 times per day for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Capsaicin
0.025% topical capsaicin applied 4 times per day for 8 weeks
placebo
vehicle gel, applied 4 times per day for 8 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Peripheral neuropathy
* Stabilized on pain medication for at least one month
* No previous invasive intervention for pain relief
Exclusion Criteria
* Allergic to capsaicin
* Refuse to participate or give consent
* Has other significant disease or receive medication that may worsen neuropathy
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bangkok Drug company
UNKNOWN
Thammasat University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kongkiat Kulkantrakorn
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kongkiat Kulkantrakorn, MD
Role: PRINCIPAL_INVESTIGATOR
Thammasat University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Thammasat University Hospital
Pathum Thani, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MTU-I-1-45/52
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.